Literature DB >> 23668977

The innate immune response during liver inflammation and metabolic disease.

Veerle Bieghs1, Christian Trautwein.   

Abstract

The role of the inflammatory response is to combat tissue injury and infection. Innate immune cells recognize cell damage or pathogen invasion with intracellular or surface-expressed pattern recognition receptors (PRRs). Activated PRRs subsequently initiate signaling cascades that trigger the release of factors promoting the inflammatory response. Because the liver is a site where foreign antigens from the gastrointestinal tract encounter the immune system, it is particularly enriched with innate immune cells. These cells can modify and disrupt critical processes implicated in metabolic disease. As such, metabolic stress initiates a feedforward cycle of inflammatory responses, resulting in a state of unresolved chronic inflammation in the liver. Accordingly, the crosstalk between these innate immune cells and the resident parenchymal cells plays an important role in the development of acute and chronic liver disease.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IL-1; TNF; Toll-like receptors; inflammasome; innate Immunity; liver Inflammation

Mesh:

Substances:

Year:  2013        PMID: 23668977     DOI: 10.1016/j.it.2013.04.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  58 in total

Review 1.  Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.

Authors:  Veerle Bieghs; Christian Trautwein
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

2.  Hepatocellular carcinoma is accelerated by NASH involving M2 macrophage polarization mediated by hif-1αinduced IL-10.

Authors:  Aditya Ambade; Abhishek Satishchandran; Banishree Saha; Benedek Gyongyosi; Patrick Lowe; Karen Kodys; Donna Catalano; Gyongyi Szabo
Journal:  Oncoimmunology       Date:  2016-09-26       Impact factor: 8.110

3.  The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis.

Authors:  Yoshitaka Kimura; Asuka Inoue; Sho Hangai; Shinobu Saijo; Hideo Negishi; Junko Nishio; Sho Yamasaki; Yoichiro Iwakura; Hideyuki Yanai; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

4.  Complement Factor D protects mice from ethanol-induced inflammation and liver injury.

Authors:  Rebecca L McCullough; Megan R McMullen; Megan M Sheehan; Kyle L Poulsen; Sanjoy Roychowdhury; Dian J Chiang; Michele T Pritchard; Juan Caballeria; Laura E Nagy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-29       Impact factor: 4.052

Review 5.  Inositol pyrophosphates: why so many phosphates?

Authors:  Stephen B Shears
Journal:  Adv Biol Regul       Date:  2014-10-05

Review 6.  Animal Models Correlating Immune Cells for the Development of NAFLD/NASH.

Authors:  Srikanth Iyer; Pramod Kumar Upadhyay; Subeer S Majumdar; Perumal Nagarajan
Journal:  J Clin Exp Hepatol       Date:  2015-07-09

7.  New medical treatment strategies for nonalcoholic steatohepatitis.

Authors:  Michael Fuchs
Journal:  Curr Treat Options Gastroenterol       Date:  2015-06

8.  Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?

Authors:  Nicolas Lanthier
Journal:  World J Hepatol       Date:  2015-09-08

9.  Comparison of silver nanoparticle-induced inflammatory responses between healthy and metabolic syndrome mouse models.

Authors:  Lisa Kobos; Saeed Alqahtani; Li Xia; Vincent Coltellino; Riley Kishman; Daniel McIlrath; Carlos Perez-Torres; Jonathan Shannahan
Journal:  J Toxicol Environ Health A       Date:  2020-04-12

10.  NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice.

Authors:  Alexander Wree; Matthew D McGeough; Maria Eugenia Inzaugarat; Akiko Eguchi; Susanne Schuster; Casey D Johnson; Carla A Peña; Lukas J Geisler; Bettina G Papouchado; Hal M Hoffman; Ariel E Feldstein
Journal:  Hepatology       Date:  2017-12-28       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.